NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
Clinical Trials
22 trialsNCT04763408 2024-07-18
STELLAR
Eisai Inc.
Completed
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT05889949 2023-06-07
Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
Sun Yat-sen University
Unknown
NCT02973204 2021-04-28
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus
Completed
NCT04553458 2020-09-17
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Sohag University
Completed
NCT03644511 2020-08-21
SORAGO-HCC
Bayer
Terminated
NCT04152356 2019-11-05
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
Guangxi Medical University
Unknown
NCT01933945 2018-11-06
OPTIMIS
Bayer
Completed
NCT01839630 2017-12-20
SUCCESS
Bayer
Completed
NCT02616692 2017-09-27
HCC Patient Preferences in Japan
Bayer
Completed
NCT01751763 2017-09-25
SECURE
Bayer
Completed
NCT00812175 2016-10-17
GIDEON
Bayer
Completed
NCT01539681 2016-02-18
STELLA
Bayer
Completed
NCT01908322 2015-11-11
SORINT
Bayer
Completed
NCT01012011 2015-09-21
Regulatory Post Marketing Surveillance Study on Nexavar®
Bayer
Completed
NCT01507740 2015-04-29
Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
Medical University Innsbruck
Terminated
NCT01411436 2015-03-04
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan
Bayer
Completed
NCT00792350 2014-05-14
INSIGHT
Bayer
Completed
NCT01328223 2011-04-04
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
China Medical University Hospital
Unknown
NCT01319942 2011-03-22
Combined Radiotherapy and Sorafenib in Patients With Hepatoma
China Medical University Hospital
Unknown
NCT01230697 2010-10-29
SORHORM
University of Turin, Italy
Unknown